Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
15.95
-1.46 (-8.39%)
At close: Apr 1, 2025, 4:00 PM
16.74
+0.79 (4.95%)
After-hours: Apr 1, 2025, 6:02 PM EDT

Korro Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-83.58-81.17-58.03-21.96
Depreciation & Amortization
3.573.632.511.6
Loss (Gain) From Sale of Assets
0.360.07-0.01
Loss (Gain) From Sale of Investments
-1.78-0.08-0.150.02
Stock-Based Compensation
4.462.381.140.81
Other Operating Activities
3.313.611.51-13.47
Change in Accounts Receivable
-1.7---
Change in Accounts Payable
-1.343.11.760.06
Change in Unearned Revenue
9.43---0.69
Change in Other Net Operating Assets
7.21.18-2.391.53
Operating Cash Flow
-60.07-67.28-53.65-32.09
Capital Expenditures
-17.9-7.84-5.21-4.45
Sale of Property, Plant & Equipment
---0.01
Investment in Securities
-105.451916.27-35.07
Investing Cash Flow
-123.3511.1611.06-39.5
Issuance of Common Stock
69.36154.550.060.03
Other Financing Activities
--12.25-0.04-0.03
Financing Cash Flow
69.36187.760.02115.95
Foreign Exchange Rate Adjustments
-0---
Net Cash Flow
-114.07131.64-42.5744.35
Free Cash Flow
-77.98-75.12-58.86-36.54
Free Cash Flow Margin
-3433.55%---
Free Cash Flow Per Share
-8.74-49.12-230.65-8.22
Cash Income Tax Paid
0.140.030.01-
Levered Free Cash Flow
-69.99-47.69-38.2-
Unlevered Free Cash Flow
-69.99-47.69-38.2-
Change in Net Working Capital
2.68-6.97-0.24-
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q